Company news

Guangxi Wuzhou Zhongheng Group Co., Ltd. Class A (SSE:600252) news

Guangxi Wuzhou Zhongheng Group Co., Ltd. Class A news releases on 6ix. Latest, Sep 25, 2026: "Guangxi Wuzhou Zhongheng Group Co., Ltd."Indicative Announcement…

Guangxi Wuzhou Zhongheng Group Co., Ltd. Class A (SSE:600252) news

Press releases & updates

"Guangxi Wuzhou Zhongheng Group Co., Ltd."Indicative Announcement on Postponement of Election of New Board of Directors

"Guangxi Wuzhou Zhongheng Group Co., Ltd."Announcement on Resignation and Appointment of Senior Executive

"Guangxi Wuzhou Zhongheng Group Co., Ltd."Announcement on Obtaining the Approval Notice for Marketing Application of a Chemical API by a Controlled Sub-subsidiary

"Guangxi Wuzhou Zhongheng Group Co., Ltd."Announcement on Initial Repurchase of Shares through Call Auction in 2026 and Progress in Share Repurchase

"Guangxi Wuzhou Zhongheng Group Co., Ltd."Announcement on Resolutions of the 47th Meeting of the 10th Board of Directors

"Guangxi Wuzhou Zhongheng Group Co., Ltd."Announcement on Extension of the Term of Nanning Zhongheng Tongde Pharmaceutical Industry Investment Fund Partnership (Limited Partnership)

"Guangxi Wuzhou Zhongheng Group Co., Ltd."Announcement on Resolutions of the 4th Extraordinary General Meeting in 2026

"Guangxi Wuzhou Zhongheng Group Co., Ltd."Announcement on Obtaining Drug Registration Certificate by Controlled Subsidiary

"Guangxi Wuzhou Zhongheng Group Co., Ltd."Announcement on Progress of Government's Acquisition and Reserve of Land Owned by a Controlled Sub-subsidiary

"Guangxi Wuzhou Zhongheng Group Co., Ltd."Announcement on Obtaining a Commitment Letter for a Special Loan for Share Repurchase from a Financial Institution

"Guangxi Wuzhou Zhongheng Group Co., Ltd."Notice on Convening the 4th Extraordinary General Meeting in 2026

"Guangxi Wuzhou Zhongheng Group Co., Ltd."Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2026

"Guangxi Wuzhou Zhongheng Group Co., Ltd."Announcement on the Signing of the "Drug Marketing Authorization Transfer Agreement" by a Controlled Subsidiary

"Guangxi Wuzhou Zhongheng Group Co., Ltd."Announcement on Shareholdings of Top 10 Shareholders and Top 10 Shareholders of Unrestricted Shares Concerning Share Repurchase

"Guangxi Wuzhou Zhongheng Group Co., Ltd."Announcement on Semi-annual Performance Forecast for 2026

"Guangxi Wuzhou Zhongheng Group Co., Ltd."Announcement on Rectification Report in Response to the Warning Letter Issued by China Securities Regulatory Commission Guangxi Bureau

"Guangxi Wuzhou Zhongheng Group Co., Ltd."Announcement on Reply to the Shanghai Stock Exchange's Information Disclosure Supervisory Inquiry Letter on the Company's 2025 Annual Report

"Guangxi Wuzhou Zhongheng Group Co., Ltd."Announcement on Progress in Government Land Reserve of the Land of Controlling Sub-subsidiary

"GUANGXI WUZHOU ZHONGHENG GROUP CO., LTD."Announcement on Appointment of Chief Financial Officer

Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026

Announcement on Holding Sub-subsidiary Obtaining Medical Device Registration Certificate

Announcement on Expiry and Non-Renewal of the Voting Rights Entrustment Agreement Signed Between the Company and a Shareholder of Lummy Pharmaceutical

Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026

Announcement on Progress in Government Land Reserve of the Land of Holding Sub-subsidiary

Announcement on Completing Deregistration of Zhongheng Group Wuzhou Pharmaceutical (Hong Kong) Co., Ltd.

Notice on Convening the 1st Extraordinary General Meeting in 2026

Announcement on Holding Sub-subsidiary Obtaining Approval for Marketing of Chemical APIs

Announcement on Completion of Private Investment Fund Filing by the Venture Capital Fund Established with Investment Participation of the Holding Subsidiary

Announcement on Convening the 2025 Annual Performance Briefing

Report for Q1 2026

Announcement on Resolutions of the 2025 Annual General Meeting

Announcement on Completion of Liquidation and Deregistration of Guangxi Lihe Zhongheng Pharmaceutical Investment Partnership (Limited Partnership)

Announcement on Progress in Government Land Reserve of the Land of Controlling Sub-subsidiary

Announcement on Resignation of Directors and Financial Person in Charge and the Election of Employee Representative Directors

Notice on Convening the 2025 Annual General Meeting

Announcement on Holding Subsidiary Obtaining Notice of Approval for Supplementary Drug Application

Announcement on Correction and Retroactive Adjustment of Accounting Errors in the Previous Period

Announcement on Signing of a Supplemental Agreement Regarding Government Land Reserve of the Land Matters of Controlling Sub-subsidiary

Announcement on Resignation of Director

Announcement on Holding Subsidiary’s Participation in Establishment of a Venture Capital Fund

Announcement on Resolutions of the 37th Meeting of the 10th Board of Directors

Announcement on Providing Guarantee for Holding Subsidiary Tianqi Jiahe

Announcement on Certain Products of Holding Subsidiary and Holding Sub-subsidiary Being Selected as Proposed Winners in the National Centralized Drug Procurement Renewal

Announcement on Absorption and Merger of its Wholly-owned Subsidiary Nanning Zhongheng Shuangqian Industrial Co., Ltd. by Guangxi Wuzhou Zhongheng Group Co., Ltd.'s Holding Subsidiary Guangxi Shuangqian Health Industry Co., Ltd.

Announcement on Holding Sub-subsidiary Obtaining Notice of Approval for Supplementary Drug Application

Announcement on the Ethical Approval Obtained for the Phase II Clinical Trial of Ferrous Ion Adsorbed Carbon Nanoparticle Suspension Injection Combined with Radiotherapy by a Holding Sub-subsidiary

Announcement on Earnings Preannouncement for 2025

Indicative Announcement on Earnings Preannouncement for 2025

Announcement on Providing Guarantee for Holding Subsidiary Double Coins Industry

Announcement on Providing Guarantee for Holding Subsidiary Guangxi Zhongheng Chinese Herbal Medicine Industry Development Co., Ltd.